LexaGene: Automated, Rapid Pathogen Detection

MiQLab automated pathogen detection system

LexaGene is a molecular diagnostics company. In fact, they’re developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected. Further, the system offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.

More on MiQLab

LexaGene’s MiQLab™ system aims to transform pathogen detection in multi-billion-dollar-markets.

MiQLab brings reference laboratory quality data to the point-of-need where samples are collected—to quickly detect multiple pathogens at once with sensitivity and specificity—and return results in ~1 hour. MiQLab is an automated, multiplexing PCR-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.

For more information on LexaGene Holdings, Inc., (TSX.V: LXG, OTCQB: LXXGF) please fill out the form below.

Request Investor Info